Dramatic regression of mass-forming gastric IgG4-related disease with inebilizumab: a case report. (PubMed, BMC Gastroenterol) - Oct 24, 2026 - "This case demonstrates that CD19-targeted B-cell depletion with inebilizumab can induce rapid, profound remission in gastric IgG4-RD, obviating the need for gastrectomy and chronic glucocorticoid therapy. These findings support early consideration of IgG4-RD in the differential diagnosis of mass-forming gastric lesions and highlight the transformative potential of mechanism-based therapy in this diagnostically challenging condition."
Journal • Cardiomyopathy • Cardiovascular • Eosinophilia • Fibrosis • Gastrointestinal Disorder • Hematological Disorders • Infectious Disease • Inflammation • Oncology • Pancreatitis
|
|
Abdul Wasay; Anisha Dash; Nasir Notta; Paul Eberts; Rami Jadallah; Shaker Barham; Vikrant Singh
|